Recent Finacing
Recent Raise
Novel Microdevices develops the Novel Dx, a rapid, portable, multiplexed point-of-care RT‑PCR platform that delivers laboratory-quality molecular detection of RSV, influenza A/B, and SARS‑CoV‑2 in ~15 minutes.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Novel Microdevices.
